Antibody | Clone | Dilution &condition | Pretreatment | Source |
---|---|---|---|---|
Fas (C-20) | Â | 1:200 RT1 h | MWO-CB | Santa Cruz Bio, Santa Cruz, CA, USA |
FADD | 64A6 | 1:20 4°C overnight | MWO-CB | Novacastra, Newcastle upon Tyne, UK |
Caspase 8 | 8CSP01 | 1:200 4°C overnight | MWO-CB | NeoMarkers, Fremont, CA, USA |
CDC25B | Â | 1:50 RT1 h | MWO-CB | Cell Signaling, Beverly, MA, USA |
Fascin | 55K-2 | 1:50 RT1 h | MWO-CB | Dako Corp, Carpinteria, CA, USA |
CK14 | LL002 | 1:50 RT1 h | MWO-CB | NeoMarkers, Fremont, CA, USA |
CK4 | 6B10 | 1:50 4°C overnight | MWO-CB | Novacastra, Newcastle upon Tyne, UK |
Annexin 1 | 29 | 1:100 RT1 h | MWO-CB | BD Transduction Laboratories, Lexington, KY |
Laminin-5γ2 | D4B5 | 1:50 RT1 h | Protease XXIV | Chemicon, Temecula, CA, USA |
SPARC | 15G12 | 1:50 RT1 h | MWO-CB | Novacastra, Newcastle upon Tyne, UK |